The move toward a less efficient, more expensive global supply chain is not a failure but a strategic correction. Over-prioritizing efficiency created a dangerous dependency on China. Diversification, while costlier in the short term, is a fundamental principle of long-term risk management.

By developing and owning the exact specifications for their fabrics—from the yarn to the finish—Faherty can move production between different manufacturers. This de-risks their supply chain from tariffs and geopolitical issues, as the "makers become less important."

The trend of moving manufacturing to countries like Mexico or Vietnam to avoid China tariffs is often driven by Chinese companies themselves. They establish clone factories abroad, sometimes with Chinese labor, meaning the economic benefits largely still flow back to China.

The push for supply chain diversification and reduced reliance on China is not a new phenomenon. The COVID-19 pandemic first exposed the critical risks of single-source dependency. Recent tariff threats are not the origin of this strategic realignment but rather a powerful accelerant, forcing companies to act on plans already in motion.

In response to unpredictable global tariffs, Hasbro invests in tooling manufacturing lines in multiple countries simultaneously. This strategy increases initial costs but provides the flexibility to shift production and avoid exposure to any single region's policies.

The Japanese government's new emphasis on economic security represents a fundamental philosophical shift away from global optimization and efficiency. This reorientation towards redundancy, autonomy, and supply chain resilience is now the primary driver of capital allocation into strategic sectors.

As the US re-shores manufacturing, VCs are strategically investing in domestic component makers (e.g., motors, magnets) that can supply multiple portfolio companies. This de-risks the entire ecosystem by creating a reliable, local supply chain for critical parts.

For final drug product manufacturing, Actuate engaged two separate US-based partners. This parallel track strategy provided crucial redundancy during the COVID pandemic, ensuring that a shutdown or material shortage (e.g., glass vials) at one plant wouldn't derail their clinical programs.

Siemens mitigates geopolitical risks and tariffs not just by being global, but by being hyper-local. Its CEO reveals that 85-87% of its production in major markets like the US and China is for that market, minimizing cross-border dependencies and the direct impact of trade wars.